Abstract
Reducing the generation of amyloid-β (Aβ) in the brain via inhibition of β-secretase or inhibition/modulation of γ-secretase has been pursued as a potential disease-modifying treatment for Alzheimer's disease. For the discovery and development of β-secretase inhibitors (BACEi), γ-secretase inhibitors (GSI), and γ-secretase modulators (GSM), Aβ in cerebrospinal fluid (CSF) has been presumed to be an effect biomarker for Aβ lowering in the brain. However, this presumption is challenged by the lack of quantitative understanding of the relationship between brain and CSF Aβ lowering. In this study, we strived to elucidate how the intrinsic pharmacokinetic (PK)/pharmacodynamic (PD) relationship for CSF Aβ lowering is related to that for brain Aβ through quantitative modeling of preclinical data for numerous BACEi, GSI, and GSM across multiple species. Our results indicate that the intrinsic PK/PD relationship in CSF is predictive of that in brain, at least in the postulated pharmacologically relevant range, with excellent consistency across mechanisms and species. As such, the validity of CSF Aβ as an effect biomarker for brain Aβ lowering is confirmed preclinically. Meanwhile, we have been able to reproduce the dose-dependent separa...Continue Reading
References
Apr 10, 1992·Science·J A Hardy, G A Higgins
Aug 1, 1996·Nature Medicine·D ScheunerS Younkin
Apr 9, 1999·Vaccine·L A HodgsonJ F Smith
Sep 29, 2004·The Journal of Pharmacology and Experimental Therapeutics·D M BartenK M Felsenstein
Jun 27, 2006·Nature Medicine·Randall J BatemanDavid M Holtzman
Feb 6, 2007·Brain Research·Janelle S CrossgroveWei Zheng
Jul 10, 2007·The Journal of Biological Chemistry·Lisa McConlogueSukanto Sinha
Oct 5, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Tong LiPhilip C Wong
Dec 20, 2007·Clinical Neuropharmacology·Eric R SiemersPatrick C May
Oct 3, 2008·Brain : a Journal of Neurology·David S KnopmanNathaniel Mercaldo
Oct 16, 2008·The Journal of Pharmacology and Experimental Therapeutics·Sethu SankaranarayananAdam J Simon
Nov 4, 2008·Biological Chemistry·Vivian HookGregory Hook
Apr 11, 2009·Annals of Neurology·Randall J BatemanDavid M Holtzman
Aug 22, 2009·Journal of Medicinal Chemistry·Anthony F KreftAlexander Porte
May 14, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Jacquelynn J CookRandall J Bateman
Dec 15, 2010·Science·Kwasi G MawuenyegaRandall J Bateman
Jan 13, 2011·Expert Opinion on Investigational Drugs·Bruno P ImbimboAlberto Pilotto
Jan 15, 2011·Expert Opinion on Therapeutic Patents·Martin PetterssonDouglas S Johnson
Mar 11, 2011·Neuro-degenerative Diseases·Julie HawkinsIshrut Hussain
Jan 1, 2009·Progress in Medicinal Chemistry·Jeffrey S Albert
May 27, 2011·Science Translational Medicine·Jasvinder K AtwalRyan J Watts
Aug 20, 2011·Nature Reviews. Drug Discovery·Eric KarranBart De Strooper
Sep 21, 2011·The Journal of Pharmacology and Experimental Therapeutics·Yasong LuDavid Riddell
Nov 18, 2011·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Patrick C MayJames E Audia
Aug 28, 2012·Neuro-degenerative Diseases·Yasong LuDavid Riddell
Citations
Oct 11, 2012·The Journal of Biological Chemistry·Fredrik JeppssonJohanna Fälting
Jul 18, 2014·Alzheimer's Research & Therapy·Jeremy H Toyn, Michael K Ahlijanian
Jan 5, 2013·European Journal of Clinical Pharmacology·Camilla NivaSandra A G Visser
Oct 5, 2013·Pharmaceutical Research·Juliette JansonSandra A G Visser
Nov 8, 2014·Science Translational Medicine·Y Joy YuRyan J Watts
Apr 26, 2013·Biochemistry·Christina J CrumpYue-Ming Li
Jan 31, 2016·The Journal of Pharmacology and Experimental Therapeutics·Eline M T van MaanenMeindert Danhof
Mar 5, 2016·Journal of Medicinal Chemistry·Mihirbaran MandalAndrew W Stamford
May 18, 2016·The Journal of Pharmacology and Experimental Therapeutics·Jeremy H ToynMichael K Ahlijanian
Aug 31, 2016·Alzheimer's Research & Therapy·Jean-François BlainGerhard Koenig
Dec 21, 2016·Journal of Medicinal Chemistry·Christopher R ButlerMichael A Brodney
Mar 23, 2017·Cold Spring Harbor Perspectives in Medicine·Douglas S JohnsonPeter H St George-Hyslop
Mar 12, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Anders LindgrenTjerk Bueters
Apr 16, 2013·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Xingrong LiuCornelis E C A Hop
Aug 23, 2012·The Journal of Pharmacology and Experimental Therapeutics·Stephen WoodToni Williamson
Jun 7, 2019·Annals of Neurology·Ting YangDennis J Selkoe
Feb 26, 2013·The European Journal of Neuroscience·Fei LiuXiao-Xin Yan
Jun 15, 2016·CPT: Pharmacometrics & Systems Pharmacology·J S KanodiaS Joseph
Mar 3, 2020·Current Alzheimer Research·Gregory Z FerlAngelica L Quartino
Sep 1, 2014·Clinical Pharmacology in Drug Development·Angelica QuartinoBjörn Paulsson
Apr 27, 2017·MedChemComm·Jonathan D LowAna E Minatti
Mar 18, 2015·Journal of Medicinal Chemistry·Michael A BrodneyBrian T O'Neill
Feb 20, 2015·Journal of Medicinal Chemistry·Christopher R ButlerBrian T O'Neill